Biotechnology
Japanese companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, MabGenesis, Inc. ranks as the top gainer, and OncoTherapy Science, Inc. sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 4588Oncolys BioPharma, Inc. | 245.18 B JPY | 7,400 JPY | −1.99% | 1.46 M | 0.67 | — | −53.18 JPY | +42.86% | 0.00% | Health technology | No rating |
 2160GNI Group Ltd. | 157.48 B JPY | 2,073 JPY | −12.90% | 5.74 M | 1.35 | — | −95.48 JPY | −2,635.21% | 0.00% | Health technology | Strong buy |
 4587Peptidream Inc. | 143.59 B JPY | 1,039 JPY | −9.10% | 1.27 M | 1.70 | — | −28.11 JPY | +27.66% | 0.00% | Health technology | Strong buy |
 4894Cuorips Inc. | 60.48 B JPY | 6,050 JPY | −7.63% | 229.4 K | 1.11 | — | −138.29 JPY | −70.48% | 0.00% | Health technology | No rating |
 504AInnovacell Inc. | 21.85 B JPY | 444 JPY | −10.30% | 151.7 K | 1.72 | — | −75.20 JPY | — | 0.00% | Health technology | No rating |
 4888STELLA PHARMA CORPORATION | 14.92 B JPY | 345 JPY | −8.00% | 905.5 K | 2.24 | — | −24.89 JPY | −524.23% | 0.00% | Health technology | No rating |
 4572Carna Biosciences, Inc. | 8.18 B JPY | 331 JPY | −7.28% | 247.2 K | 1.78 | — | −111.45 JPY | +2.08% | 0.00% | Health technology | No rating |
 4584Kidswell Bio Corporation | 7.59 B JPY | 137 JPY | −6.16% | 420.3 K | 1.64 | — | −7.61 JPY | −212.21% | 0.00% | Health technology | No rating |
 7096StemCell Institute | 7.02 B JPY | 639 JPY | −7.93% | 18.6 K | 4.67 | 43.88 | 14.56 JPY | −40.57% | 0.00% | Health technology | No rating |
 4583Chiome Bioscience Inc. | 6.96 B JPY | 74 JPY | −10.84% | 2.05 M | 3.51 | — | −13.11 JPY | +16.36% | 0.00% | Health technology | No rating |
 4564OncoTherapy Science, Inc. | 6.94 B JPY | 16 JPY | −5.88% | 207.92 M | 0.99 | — | −2.44 JPY | +19.03% | 0.00% | Health technology | No rating |
 520AJ-Pharma Co.,Ltd. | 6.7 B JPY | 332 JPY | −10.75% | 194 K | 1.27 | — | — | — | 0.00% | Health technology | No rating |
| 6653AMabGenesis, Inc. | 6.17 B JPY | 749 JPY | +2.60% | 854.4 K | — | — | — | — | — | Health technology | No rating |
 4892Cyfuse Biomedical K.K. | 5.52 B JPY | 500 JPY | −7.41% | 104.3 K | 3.37 | — | −82.47 JPY | +18.43% | 0.00% | Health technology | No rating |
 2370MEDINET Co., Ltd. | 5.41 B JPY | 17 JPY | −5.56% | 2.19 M | 2.36 | — | −4.06 JPY | +25.71% | 0.00% | Health technology | No rating |
 4263SUSMED,Inc. | 5.29 B JPY | 276 JPY | −9.21% | 246 K | 1.82 | — | −22.72 JPY | −27.77% | 0.00% | Health technology | Strong buy |
 4884Kringle Pharma, Inc. | 4.83 B JPY | 476 JPY | −6.48% | 517.6 K | 1.96 | — | −110.73 JPY | +22.75% | 0.00% | Health technology | No rating |
 206APRISM BioLab Co. LTD | 4.41 B JPY | 103 JPY | −9.65% | 348.4 K | 3.79 | — | −23.71 JPY | +33.14% | 0.00% | Health technology | No rating |
 177AKohjin Bio Co.,Ltd. | 3.65 B JPY | 684 JPY | −4.20% | 6.5 K | 1.72 | 27.57 | 24.81 JPY | −82.25% | 1.40% | Health technology | No rating |
 2342TRANS GENIC GROUP INC. | 3.51 B JPY | 197 JPY | −7.08% | 137 K | 4.07 | 103.14 | 1.91 JPY | — | 0.00% | Health technology | No rating |
 6090Human Metabolome Technologies, Inc. | 3.45 B JPY | 560 JPY | −1.93% | 13.8 K | 3.22 | 15.50 | 36.14 JPY | −17.23% | 3.09% | Health technology | No rating |
 4883Modalis Therapeutics Corporation | 3.01 B JPY | 24 JPY | −7.69% | 4.1 M | 4.18 | — | −24.03 JPY | −5.66% | 0.00% | Health technology | No rating |
 4881FunPep Co., Ltd. | 2.03 B JPY | 37 JPY | −7.50% | 513.6 K | 2.96 | — | −37.74 JPY | +10.12% | 0.00% | Health technology | No rating |
 130AVeritas In Silico Inc. | 1.93 B JPY | 266 JPY | −5.34% | 63.7 K | 1.00 | — | −96.78 JPY | −89.83% | 0.00% | Health technology | No rating |